Tumor purity is also thought to impinge on the efficacy of ICI treatment, and NCAPG2 displayed a significant correlation with purity, which was more prominent in GBM, SARC, SKCM, ACC, LUSC, STAD and others, with some similarity to TMB and MSI (Figure 7C). This evidence concerns the gene NCAPG2 and neoplasm.